Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng Jin

Showing results (771-780 of 778) with videos related to

Pageof 78
Sort By:
You have reached the last page of results.This site can display upto 778 results.
Science Advances|November 29, 2023
<i>ROBO1</i> deficiency impairs HSPC homeostasis and erythropoiesis via <i>CDC42</i> and predicts poor prognosis in MDSJia-Cheng Jin, Bing-Yi Chen, Chu-Han Deng, et al.
Blood|June 15, 2023
The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironmentMing-Yue Fei, Yong Wang, Bin-He Chang, et al.
Hepatology (Baltimore, Md.)|November 10, 2025
Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204)Zhi-Cheng Jin, Jingwei Wei, Yu-Dong Xiao, et al.
Ecology Letters|February 2, 2011
Abundance of introduced species at home predicts abundance away in herbaceous communitiesJennifer Firn, Joslin L Moore, Andrew S MacDougall, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 27, 2024
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213)Zhi-Cheng Jin, Jia-Wei Zhou, Jian-Jian Chen, et al.
Eclinicalmedicine|May 15, 2024
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation studyZhi-Cheng Jin, Jian-Jian Chen, Xiao-Li Zhu, et al.
Science (New York, N.Y.)|September 24, 2011
Productivity is a poor predictor of plant species richnessPeter B Adler, Eric W Seabloom, Elizabeth T Borer, et al.
Signal Transduction and Targeted Therapy|February 8, 2023
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, et al.
Pageof 78

Showing results (771-780 of 778) with videos related to

Sort By:
Pageof 78
You have reached the last page of results.This site can display upto 778 results.
Science Advances|November 29, 2023
<i>ROBO1</i> deficiency impairs HSPC homeostasis and erythropoiesis via <i>CDC42</i> and predicts poor prognosis in MDSJia-Cheng Jin, Bing-Yi Chen, Chu-Han Deng, et al.
Blood|June 15, 2023
The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironmentMing-Yue Fei, Yong Wang, Bin-He Chang, et al.
Hepatology (Baltimore, Md.)|November 10, 2025
Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204)Zhi-Cheng Jin, Jingwei Wei, Yu-Dong Xiao, et al.
Ecology Letters|February 2, 2011
Abundance of introduced species at home predicts abundance away in herbaceous communitiesJennifer Firn, Joslin L Moore, Andrew S MacDougall, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 27, 2024
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213)Zhi-Cheng Jin, Jia-Wei Zhou, Jian-Jian Chen, et al.
Eclinicalmedicine|May 15, 2024
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation studyZhi-Cheng Jin, Jian-Jian Chen, Xiao-Li Zhu, et al.
Science (New York, N.Y.)|September 24, 2011
Productivity is a poor predictor of plant species richnessPeter B Adler, Eric W Seabloom, Elizabeth T Borer, et al.
Signal Transduction and Targeted Therapy|February 8, 2023
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, et al.
Pageof 78